Nikolaos Papanikolaou
Nikolaos Papanikolaou, PhD (Male), is a Principal Investigator in Oncologic Imaging and research group leader of the Computational Clinical Imaging Group in the Centre for the Unknown at Champalimaud Foundation, Lisbon, Portugal. Recently, he has appointed as the Machine Learning Imaging Lead for the AI Hub at Royal Marsden and recognized as an honorary reader at the Institute of Cancer Research, in London, UK. Dr. Nikolaos Papanikolaou studied biomedical engineering while he obtained his PhD from the Medical School of the University of Crete. He has published 120 scientific papers in peer-reviewed international journals and 20 chapters in international books. He has delivered more than 100 invited lectures at international congresses and educational courses. The main focus of his research is the development and validation of imaging biomarkers, radiomic signatures and AI models for cancer applications. He recently initiated the development of a Radiomics Network comprising luminary clinical sites in the US and Europe to advance research in that area of Radiomics. He is the section editor on AI, Radiomics, and Machine Learning in Cancer Imaging, and he is chairing the e-learning subcommittee of the International Cancer Imaging Society. He is the scientific coordinator of the Pro-Cancer-I project.
